Yan-Hong Li

4PUBLICATIONS
3CO-AUTHORS
Biomolecular modelling and designGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 26, 2022
Identification of potential immunomodulators from Pulsatilla decoction that act on therapeutic targets for ulcerative colitis based on pharmacological activity, absorbed ingredients, and in-silico molecular docking.

Li-Rong Deng, Qian Han, Min Zou

|Oct 27, 2022
Evaluating gliclazide for the treatment of type 2 diabetes mellitus.

Brian Tomlinson, Yan-Hong Li, Paul Chan

|Aug 18, 2021
Correction to Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.

Qian Han, Hua-Zheng Tang, Min Zou

|May 21, 2020
Anti-inflammatory Efficacy of Combined Natural Alkaloid Berberine and S1PR Modulator Fingolimod at Low Doses in Ulcerative Colitis Preclinical Models.

Qian Han, Hua-Zheng Tang, Min Zou

Pageof 1

Frequent Collaborators

2 joint publications

Ling Wang

1 joint publications

Brian Tomlinson

1 joint publications

Paul Chan